NCT00653302View on ClinicalTrials.gov

Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine)

PHASE4CompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

September 30, 2004

Study Completion Date

October 31, 2005

Conditions
Type 2 Diabetes
Interventions
DRUG

Lantus (insulin glargine) + Glucophage (Metformin)

Trial Locations (1)

Unknown

Sanofi-aventis administrative office, Paris

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00653302 - Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine) | Biotech Hunter | Biotech Hunter